“…AIIt was identified as a receptor for plasmin-induced signaling in human peripheral monocytes, which involved the activation of nuclear factor (NF)-kB, JAK/ signal transducers and activators of transcription (STAT) and p38 mitogen-activated protein kinase (MAPK) signaling cascades, leading to a full-scale proinflammatory response (Laumonnier et al, 2006). It is possible, that binding of PG to ANX II may mediate an activation of a similar cascade of signaling molecules in target cells, as we and others have reported activation of Src, phosphatidylinositol 3 0 -kinase/Akt, JAK2, STAT5/3, extracellular signal-regulated kinases, p38 MAPK and NFkB, in response to PG Brown et al, 2003;Ferrand et al, 2005;Rengifo-Cam and Singh, 2005). Importantly, our preliminary findings suggest that treatment of IEC-18 cells with anti-ANX II-Abs results in attenuating the activation of many of the above-described signaling molecules, in response to PG (unpublished data from our laboratory).…”